Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Han, Dong Cheol ^a,b   Hoffman, Brenda B ^a   Hong, Soon Won ^a,b   Guo, Jia ^a   Ziyadeh, Fuad N ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Collagen type IV; Fibronectin; Glucose; Nephropathy; Osmotic minipumps; Proximal tubule; Transforming growth factor 1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COLLAGEN TYPE 1; FIBRONECTIN; GLUCOSE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

EID: 0002779849     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.4.f628     Document Type: Article

References (34)

1. Agrawal S. Antisense oligonucleotide: towards clinical trials. TIBTECH 14: 376-387, 1996.
2. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, and Imai E. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix in experimental glomerulonephritis. Kidney Int 50: 148-155, 1996.
3. Bleyer A, Fumo P, Snipes ER, Goldfarb S, Simmons DA, and Ziyadeh FN. Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int 45: 659-666, 1994.
4. Bunnell BA, Askari FK, and Wilson JM. Targeted delivery of antisense oligonucleotides by molecular conjugates. Somatic Cell Mol Genet 18: 559-569, 1992.
5. Dean NM and McKay R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynuceotides. Proc Natl Acad Sci USA 91: 11762-11766, 1994.
6. Hanss B, Rappaport J, Bruggeman L, Coffman T, and Klotman P. Kidney serves as a critical organ for the handling of systemic antisense for gene therapy. Clin Res 42: 221, 1994.
7. Haverty T, Kelly CJ, Hines WH, Amenta PS, Watanabe M, Harper RA, Kefalides NA, and Neilson EG. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368, 1988.
8. Hoffman BB, Sharma K, Zhu Y, and Ziyadeh FN. Transcriptional activation of TGF-β1 in mesangial cell culture by high glucose concentration. Kidney Int 54: 1107-1116, 1998.
9. Ihm C, Lee G, Nast C, Artishevsky A, Guillermo R, Levin R, Glassock R, and Adler S. Early increased procollagen α1(FV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41: 768-777, 1992.
10. Kolm V, Sauer U, Olgemoller B, and Schleicher ED. High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol Renal Fluid Electrolyte Physiol 270: F812-F821, 1996.
11. Mogyorosi A and Ziyadeh FN. Update on pathogenesis, markers, and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5: 243-253, 1996.
12. Mogyorosi A and Ziyadeh FN. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol Renal Physiol. 275: F827-F832, 1998.
13. +/Pi cotransporter by antisense oligonucleotides. Proc Natl Acad Sci USA 93: 4903-4906, 1996.
14. Park I-S, Kiyomoto H, Abboud S, and Abboud H. Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46: 473-480, 1997.
15. Rappaport J, Hanss B, Kopp JB, Copeland TD, Bruggeman LA, Coffman TM, and Klotman PE. Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int 47: 1462-1469, 1995.
16. Rasch R. Tubular lesions in streptozotocin diabetic rats. Diabetologia 27: 32-37, 1984.
17. Rocco M, Chen Y, Goldfarb S, and Ziyadeh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41: 107-114, 1992.
18. Sawai K, Miyao T, Takakura Y, and Hashida M. Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney. Antisense Res Dev 5: 270-287, 1995.
19. Seyer-Hansen K. Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23: 643-646, 1983.
20. Seyer-Hansen K, Hansen J, and Gunderson HJG. Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia 18: 501-505, 1980.
21. Shankland SJ and Scholey JW. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46: 430-442, 1994.
22. Sharma K, Guo J, Jin Y, and Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996.
23. Sharma K, Han DC, Mogyorosi A, and Ziyadeh FN. Structural and functional consequences of streptozotocin-induced diabetes on the kidney. In: Experimental Models of Diabetes, edited by McNeill JH. Boca Raton, FL: CRC, 1999, p. 39-62.
24. Sharma K and Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol Renal Fluid Electrolyte Physiol 267: F1094-F1101, 1994.
25. Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, and DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324: 1626-1632, 1991.
26. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 372: 333-335, 1994.
27. Wang H, Watkins C, and Malbon CC. Antisense oligodeoxynucleotides to G-S protein a-subunit sequence accelerate differentation of fibroblasts to adipocytes. Nature 358: 334-337, 1992.
28. Wolf G and Neilson EG. Angiotensin II induces hypertrophy in cultured murine proximal tubular cells. Am J Physiol Renal Fluid Electrolyte Physiol 259: F768-F777, 1990.
29. Wolf G, Neilson EG, Goldfarb S, and Ziyadeh FN. The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 176: 902-909, 1991.
30. Wolf G and Ziyadeh FN. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29: 153-163, 1997.
31. Zhang R, Diasio RB, Lu Z, Liu T, Jiang Z, Galbraith WM, and Agrawal S. Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. Biochem Pharmacol 49: 929-939, 1995.
32. Ziyadeh FN, Sharma K, Ericksen M, and Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994.
33. Ziyadeh FN, Simmons DA, Snipes ER, and Goldfarb S. Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol 1: 1220-1229, 1991.
34. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, and Haverty TP. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 259: F704-F714, 1990.